Page last updated: 2024-08-24

3-iodobenzylguanidine and Dancing Eyes-Dancing Feet Syndrome

3-iodobenzylguanidine has been researched along with Dancing Eyes-Dancing Feet Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bares, R; Ebinger, M; Handgretinger, R; Schäfer, JF; Storz, C; Tsiflikas, I1
Herman, TE; Siegel, MJ1
Applegate, K; Lee, ND; McGarvey, CK; Sokol, DK1

Other Studies

3 other study(ies) available for 3-iodobenzylguanidine and Dancing Eyes-Dancing Feet Syndrome

ArticleYear
Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
    BMC medical imaging, 2019, 08-20, Volume: 19, Issue:1

    Topics: 3-Iodobenzylguanidine; Adrenalectomy; Female; Ganglioneuroblastoma; Humans; Infant; Magnetic Resonance Imaging; Male; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Sensitivity and Specificity; Whole Body Imaging

2019
Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma.
    Clinical pediatrics, 2009, Volume: 48, Issue:3

    Topics: 3-Iodobenzylguanidine; Ataxia; Child, Preschool; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Neuroblastoma; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Ultrasonography

2009
False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (acth).
    Journal of child neurology, 2006, Volume: 21, Issue:7

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Child, Preschool; False Positive Reactions; Female; Hormones; Humans; Neuroblastoma; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Radiopharmaceuticals

2006